Interestingly, idiopathic hyposmia has been associated with a 5% annual reduction in dopamine transporter (DAT) binding, a rate comparable to early-stage PD, further supporting its role as a preclinical biomarker (Jennings et al., 2017). The gene discussed is SLC6A3; the disease is Parkinson disease.